Connecting Care: Outpatient Treatment of COVID-19 With Neutralizing Monoclonal Antibodies - a podcast by ReachMD

CME credits: 0.75

Valid until: 29-01-2022

Claim your CME credit at https://reachmd.com/programs/cme/connecting-care-outpatient-treatment-covid-19-neutralizing-monoclonal-antibodies/12155/

The United States is one of the hardest hit countries with SARS-CoV-2 with many more deaths expected in early 2021. Outpatient infusion treatment with neutralizing monoclonal antibodies (nAbs) is an important treatment option for some patients. This 30-minute ReachMD program helps you recognize appropriate patients for nAb-therapy and presents the most recent evidence on ambulatory options. Get expert perspectives from a physician and pharmacist as they present compelling case studies. This broadcast replay includes a pre-read summarizing key clinical trial information.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD